These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 34990423)

  • 1. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
    Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
    Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
    Benlice C; Koc MA; Gulcu B; Bilgin IA; Akyol C; Baca B; Ozturk E; Guney Y; Utkan G; Er O; Agaoglu F; Yildirim I; Avci N; Elhan AH; Kuzu MA
    Dis Colon Rectum; 2023 May; 66(5):681-690. PubMed ID: 36856669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Survival After Adjuvant Therapy in Locally Advanced Rectal Cancer Patients With Pathologic Complete Response.
    Lai SH; Vogel JD; Vemuru S; Messersmith W; Lieu C; McCarter MD; Birnbaum E; Chapman BC
    Dis Colon Rectum; 2023 Jul; 66(7):983-993. PubMed ID: 36602514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Total Neoadjuvant Therapy on Postoperative Outcomes After Proctectomy for Rectal Cancer.
    Xu Z; Valente MA; Sklow B; Liska D; Gorgun E; Kessler H; Rosen DR; Steele SR
    Dis Colon Rectum; 2023 Jul; 66(7):1022-1028. PubMed ID: 36538720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total Neoadjuvant Therapy Significantly Increases Complete Clinical Response.
    Rettig RL; Beard BW; Ryoo JJ; Kulkarni S; Gulati M; Tam M; Attaluri V
    Dis Colon Rectum; 2023 Mar; 66(3):374-382. PubMed ID: 35239525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer.
    Elshami M; Goldstone RN; Blaszkowsky LS; Cusack JC; Hong TS; Wo JY; Qadan M
    Dis Colon Rectum; 2022 Oct; 65(10):1224-1231. PubMed ID: 35714358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bowel Functional Outcomes After Long-Course or Short-Course Radiation for Advanced Rectal Cancers: A Propensity-Matched Analysis.
    Kazi M; Jajoo B; Kapadia R; Dohale S; Bhuta P; Desouza A; Saklani A
    Dis Colon Rectum; 2022 Dec; 65(12):1494-1502. PubMed ID: 36382840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
    Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
    Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Propensity Score-Matched Analysis of the Impact of Neoadjuvant Radiation Therapy on the Outcomes of Stage II and III Mucinous Rectal Carcinoma.
    Emile SH; Horesh N; Freund MR; Silva-Alvarenga E; Wexner SD
    Dis Colon Rectum; 2024 May; 67(5):655-663. PubMed ID: 38231014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downstaging in Advanced Rectal Cancers: A Propensity-Matched Comparison Between Short-Course Radiotherapy Followed by Chemotherapy and Long-Course Chemoradiotherapy.
    Kammar PS; Garach NR; Masillamany S; de'Souza A; Ostwal V; Saklani AP
    Dis Colon Rectum; 2022 Oct; 65(10):1215-1223. PubMed ID: 34907988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is There a Role for Neoadjuvant Systemic Therapy for cT4bM0 Colon Cancer? A Propensity Score-Matched Analysis of the National Cancer Database.
    Kamel MK; Shchatsko A; Keane CA; Serpa E; Al-Qudah G; Rahouma M; Nituica C; Blebea J; Marar O
    Dis Colon Rectum; 2023 Nov; 66(11):1435-1448. PubMed ID: 36876973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
    Zhang J; Li J; Huang M; Xie X; Cai Y; Hu H; Ling J; Wu Z; Deng Y
    Dis Colon Rectum; 2023 Jul; 66(7):934-945. PubMed ID: 35834598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal Cancer Survival for Residual Carcinoma In Situ Versus Pathologic Complete Response After Neoadjuvant Therapy.
    Kohrman NM; Wlodarczyk JR; Ding L; McAndrew NP; Algaze SD; Cologne KG; Lee SW; Koller SE
    Dis Colon Rectum; 2024 Jul; 67(7):920-928. PubMed ID: 38498775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant Therapy in Stage II/III Rectal Cancer: A Retrospective Study in a Disparate Population and the Effect on Survival.
    Gan T; Chen Q; Huerta CT; Huang B; Evers BM; Patel JA
    Dis Colon Rectum; 2021 Oct; 64(10):1212-1221. PubMed ID: 34516443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and Nonoperative Management.
    Feferman Y; Rosen RY; Gebran S; Yuval JB; Kerioui M; Gönen M; Wei IH; Widmar M; Nash GM; Weiser MR; Paty PB; Hajj C; Roth O'Brien DA; Romesser PB; Crane CH; Smith JJ; Garcia Aguilar J; Pappou EP
    Dis Colon Rectum; 2024 Apr; 67(4):496-504. PubMed ID: 38127627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy.
    Chapman BC; Lai SH; Friedrich T; Lieu CH; Moskalenko M; Olsen JR; Herter W; Birnbaum EH; McCarter MD; Vogel JD
    Dis Colon Rectum; 2023 Apr; 66(4):521-530. PubMed ID: 34984995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and Outcomes of Upstaging in Rectal Cancer Patients Who Did Not Receive Preoperative Therapy.
    Antunez AG; Kanters AE; Regenbogen SE
    Dis Colon Rectum; 2023 Jan; 66(1):59-66. PubMed ID: 35905174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lateral Pelvic Nodal Management and Patterns of Failure in Patients Receiving Short-Course Radiation for Locally Advanced Rectal Cancer.
    Hassanzadeh C; Mirza K; Kalaghchi B; Fallahian F; Chin RI; Roy A; Stowe H; Low G; Pedersen K; Wise P; Glasgow S; Roach M; Henke L; Badiyan S; Mutch M; Kim H
    Dis Colon Rectum; 2024 Jan; 67(1):54-61. PubMed ID: 37787502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circumferential Resection Margin as Predictor of Nonclinical Complete Response in Nonoperative Management of Rectal Cancer.
    Chin RI; Schiff JP; Shetty AS; Pedersen KS; Aranha O; Huang Y; Hunt SR; Glasgow SC; Tan BR; Wise PE; Silviera ML; Smith RK; Suresh R; Byrnes K; Samson PP; Badiyan SN; Henke LE; Mutch MG; Kim H
    Dis Colon Rectum; 2023 Jul; 66(7):973-982. PubMed ID: 36876988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.